Clinical Trial Update: Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative chemotherapy plus PD-1 antibody for gastric cancer; efficacy and safety data not yet reported in the excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Chemotherapy regimen (perioperative)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN